Thomas Lyons, DPM
Podiatrist · Boston, MANPI 1841239878
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,200 of the $1,962 with a category attached, or 61.2%. Kairos Surgical Inc accounts for 62.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $1,298 and has fallen 82.1% since, to $232 in 2025.
Across 27 payments — averaging $72.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$1K
- Smith+Nephew$262
- Stryker$180
- Treace Medical Concepts, Inc.$123
- Orthofix Medical, Inc.$79
- Tactile Systems Technology Inc$40
- plus $44 from 2 others
What the payments were for
- Food & beverage$76239%
- Education$1,20061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 3 | $1,235 |
| Smith+Nephew | 14 | $262 |
| Stryker(2 entities) | 2 | $180 |
| Treace Medical Concepts, Inc. | 1 | $123 |
| Orthofix Medical, Inc. | 3 | $79 |
| Tactile Systems Technology Inc | 2 | $40 |
| Bioventus LLC | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,962 in reported general payments places this provider in the 70th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 16 | $207 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Boston
- Thanh DinhBoston$48K
- Barry RosenblumBoston$43K
- Elizabeth SandersBoston$8K
- John GiuriniBoston$6K
- Daphne RobertBoston$5K
- Hau PhamBoston$5K
- Jennifer SkolnikBoston$4K
- Ashley DanielBoston$2K
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.